venBio Overview
venBio is a life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies with a focus on novel therapeutics for unmet medical needs. They are mindful of potential acquisition partners from the outset, and they ensure that their companies are best positioned to meet their requirements. This includes intellectual property (IP), chemistry, manufacturing (CMC), and the details of clinical trials, including indication, trial design, endpoints, powering, and regulatory considerations.
Latest News
growth-positive
Venture capital veteran venBio raises $528M for life sciences investment
Venture capital firm venBio has raised $528 million for its fifth fund, Fund V, to invest in biotechs working on diseases with unmet needs. The fundraising began in mid-April, with investors coming from diverse backgrounds. The San Francisco-based firm plans to invest across all stages of clinical development. venBio has previously invested in over 40 companies, many of which have been acquired or gone public.
InvestmentAcquisition
Team Members
4
Web & Social Links
| Website | www.venbio.com/ |
Locations
San Francisco, CA, USA
Photos & Videos
No files yet
